Cargando…
Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393637/ https://www.ncbi.nlm.nih.gov/pubmed/36003503 http://dx.doi.org/10.3389/fphar.2022.988334 |
| _version_ | 1784771312298754048 |
|---|---|
| author | Shi, Zhi Wang, Ning Zhang, Ying-Jie Zheng, Yi-Chao |
| author_facet | Shi, Zhi Wang, Ning Zhang, Ying-Jie Zheng, Yi-Chao |
| author_sort | Shi, Zhi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9393637 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93936372022-08-23 Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer Shi, Zhi Wang, Ning Zhang, Ying-Jie Zheng, Yi-Chao Front Pharmacol Pharmacology Frontiers Media S.A. 2022-08-08 /pmc/articles/PMC9393637/ /pubmed/36003503 http://dx.doi.org/10.3389/fphar.2022.988334 Text en Copyright © 2022 Shi, Wang, Zhang and Zheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Shi, Zhi Wang, Ning Zhang, Ying-Jie Zheng, Yi-Chao Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer |
| title | Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer |
| title_full | Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer |
| title_fullStr | Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer |
| title_full_unstemmed | Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer |
| title_short | Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer |
| title_sort | editorial: epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393637/ https://www.ncbi.nlm.nih.gov/pubmed/36003503 http://dx.doi.org/10.3389/fphar.2022.988334 |
| work_keys_str_mv | AT shizhi editorialepigeneticmechanismsandposttranslationalmodificationsasnoveltherapeutictargetsincancer AT wangning editorialepigeneticmechanismsandposttranslationalmodificationsasnoveltherapeutictargetsincancer AT zhangyingjie editorialepigeneticmechanismsandposttranslationalmodificationsasnoveltherapeutictargetsincancer AT zhengyichao editorialepigeneticmechanismsandposttranslationalmodificationsasnoveltherapeutictargetsincancer |